We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cedars-Sinai Hospital to Use FitBit to Measure Patient Mobility

By HospiMedica International staff writers
Posted on 03 Feb 2016
Cedars-Sinai Medical Center (Los Angeles, CA, USA) is conducting a study to see if using an activity bracelet could help assess if oncologic patients are active enough for chemotherapy.

The short, two-week trial will enroll 30 patients in advanced stages of cancer who are ambulatory, over 18, and have access to an internet-connected smartphone. More...
The trial will mainly be a feasibility study, seeing how effective a Fitbit (San Francisco, CA, USA) activity bracelet, as well as questionnaires, are at monitoring the target population. All 30 patients will be given Fitbit Charge HR device and will be asked to wear it at all times, other than in the bath and other times the tracker would be submerged.

The patients will also fill out questionnaires at two oncologist visits during the trial period, and again at a six month follow-up. Researchers will also review mortality and hospitalization for the subjects, as well as whether they wore the device as directed. They will also examine whether the combination of the Fitbit device and the patient-reported-outcome questionnaires can help physicians screen patients for subjective measures such as fatigue, distress, pain, and trouble sleeping, which patients can tend to under-report.

“What we know is that individuals who are up and about tend to be more able to tolerate chemotherapy and have a greater potential for benefitting from it,” said lead investigator Arvind Shinde, MD, of the departments of supportive care medicine, hematology, and oncology. “People who are spending more time in bed usually get harmed by the treatment we give, even if the cancer is responsive to the treatment.”

“A 30-patient study is not enough to give us all the data we need; the two-week trial is something of a dry run to get the kinks of data collection ironed out. The next step will be to do a larger study across multiple tumor types and follow people longitudinally for a much longer period of time,” added Dr. Shinde. “We can see how they do as they progress through their treatments, follow their ups and downs. We’ll be able to get changes over baseline and create a better algorithm for this assessment.”

The Fitbit Charge HR is an activity wrist band that offers continuous heart rate monitoring for better estimation of daily activity, tracking workouts, and monitoring resting heart rate and sleep quality. The advanced tracking records daily steps and calories by day and sleep by night, switching between modes based on movement and heart rate data. The device is linked by an app to a smartphone, allowing real time monitoring of daily data. The Charge HR is available in a range of colors, including black, plum, blue, teal, and tangerine.

Related Links:

Cedars-Sinai Medical Center
Fitbit



Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Wound Irrigation Solution
Prontosan®
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.